• s  possessing the ability to elicit an immune response

News & Articles

• Novavax Announces Positive Top-Line Results From Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly
  ROCKVILLE, Md. -- Novavax, Inc. today announced positive top-line safety and immunogenicity data for its respiratory syncytial virus (RSV) vaccine candidate from a dose-ranging Phase 1 study in elderly ...
  July 2, 2013 - GlobeNewswire via Yahoo! Finance

Quotes

• Ellen Vitetta in Newswise (press release)
  We have shown that this vaccine is safe and immunogenic,said Dr. Vitetta. "Now we need to tinker with the dose and formulation to give the longest-lasting and most robust immunity."